Explore ›
Finding
Finding
improvement
Fenofibrate added to simvastatin reduced progression of diabetic retinopathy by 36.3% (p=0.006) compared with simvastatin alone, measured by combined progression on funduscopic examination and need for laser photocoagulation.
| Effect size | -36.3% |
| Follow-up | 4.7 years |
| Comparator | Placebo added to simvastatin (20-40 mg/day) |
| Effect summary | improvement; -36.3% |
Connected entities
Interventions
Conditions
Populations
Source
PMC4509601
The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus